Bursehernin exhibits significant anti-inflammatory and antioxidant properties, making it a compound of interest in pharmaceutical and nutraceutical applications. It has been studied for its potential in managing metabolic disorders, including diabetes, due to its ability to modulate glucose uptake and improve insulin sensitivity. Additionally, bursehernin shows antimicrobial activity against certain pathogenic bacteria, suggesting utility in developing natural antimicrobial agents. Its cytotoxic effects on select cancer cell lines indicate possible use in oncology research, particularly in early-stage drug discovery for anticancer agents. Ongoing studies also explore its role in hepatoprotection, supporting liver health against toxin-induced damage.